But Hwang said activity has been slow so far as securities firms await licences to trade, which he expects should be issued by the end of August. He added that securities firms have also yet to make full preparations for entry into the OTC derivatives business.
"Securities firms are not quite ready to offer these kinds of products yet, and will need some time to develop their systems, their people skills and their know-how," he said. "I think it will take a little bit more time for them to begin."
Currently, IBK is only involved in proprietary trading of equity derivatives, but plans to begin structuring products such as equity-linked notes, warrants and principal-protected notes with equity index options, by as early as September this year.
While there are plans to make new hires later in the year, the bank plans to take a wait-and-see approach to see how the market develops before making any moves. "We will form our game-plan according to market developments," said Hwang.
The business will be run through the existing seven-strong financial engineering team.
The week on Risk.net, July 7-13, 2018Receive this by email